BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34272480)

  • 1. Mutation in FBXO32 causes dilated cardiomyopathy through up-regulation of ER-stress mediated apoptosis.
    Al-Yacoub N; Colak D; Mahmoud SA; Hammonds M; Muhammed K; Al-Harazi O; Assiri AM; Al-Buraiki J; Al-Habeeb W; Poizat C
    Commun Biol; 2021 Jul; 4(1):884. PubMed ID: 34272480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FBXO32, encoding a member of the SCF complex, is mutated in dilated cardiomyopathy.
    Al-Yacoub N; Shaheen R; Awad SM; Kunhi M; Dzimiri N; Nguyen HC; Xiong Y; Al-Buraiki J; Al-Habeeb W; Alkuraya FS; Poizat C
    Genome Biol; 2016 Jan; 17():2. PubMed ID: 26753747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A substitution mutation in cardiac ubiquitin ligase, FBXO32, is associated with an autosomal recessive form of dilated cardiomyopathy.
    Al-Hassnan ZN; Shinwari ZM; Wakil SM; Tulbah S; Mohammed S; Rahbeeni Z; Alghamdi M; Rababh M; Colak D; Kaya N; Al-Fayyadh M; Alburaiki J
    BMC Med Genet; 2016 Jan; 17():3. PubMed ID: 26768247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endophilin-A Deficiency Induces the Foxo3a-Fbxo32 Network in the Brain and Causes Dysregulation of Autophagy and the Ubiquitin-Proteasome System.
    Murdoch JD; Rostosky CM; Gowrisankaran S; Arora AS; Soukup SF; Vidal R; Capece V; Freytag S; Fischer A; Verstreken P; Bonn S; Raimundo N; Milosevic I
    Cell Rep; 2016 Oct; 17(4):1071-1086. PubMed ID: 27720640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
    Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
    Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FBXO32 Targets c-Myc for Proteasomal Degradation and Inhibits c-Myc Activity.
    Mei Z; Zhang D; Hu B; Wang J; Shen X; Xiao W
    J Biol Chem; 2015 Jun; 290(26):16202-14. PubMed ID: 25944903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel likely pathogenic variant in the FBXO32 gene associated with dilated cardiomyopathy according to whole‑exome sequencing.
    Ghasemi S; Mahdavi M; Maleki M; Salahshourifar I; Kalayinia S
    BMC Med Genomics; 2022 Nov; 15(1):234. PubMed ID: 36344977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinoma.
    Guo W; Zhang M; Shen S; Guo Y; Kuang G; Yang Z; Dong Z
    Cancer; 2014 Aug; 120(16):2412-23. PubMed ID: 24798237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FBXO32 targets PHPT1 for ubiquitination to regulate the growth of EGFR mutant lung cancer.
    Zhang N; Liao Y; Lv W; Zhu S; Qiu Y; Chen N; Xiao M; Zhang H
    Cell Oncol (Dordr); 2022 Apr; 45(2):293-307. PubMed ID: 35411430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNMT1-mediated regulating on FBXO32 promotes the progression of glioma cells through the regulation of SKP1 activity.
    Quan J; Ma C
    Environ Toxicol; 2024 Feb; 39(2):783-793. PubMed ID: 37782699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of Atrogin-1/FBXO32 is not necessary for cartilage destruction in mouse models of osteoarthritis.
    Kim HE; Rhee J; Park S; Yang J; Chun JS
    Osteoarthritis Cartilage; 2017 Mar; 25(3):397-400. PubMed ID: 27480933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSOX1, a novel actor of cardiac protection upon acute stress in mice.
    Caillard A; Sadoune M; Cescau A; Meddour M; Gandon M; Polidano E; Delcayre C; Da Silva K; Manivet P; Gomez AM; Cohen-Solal A; Vodovar N; Li Z; Mebazaa A; Samuel JL
    J Mol Cell Cardiol; 2018 Jun; 119():75-86. PubMed ID: 29723491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TULP1 Missense Mutations Induces the Endoplasmic Reticulum Unfolded Protein Response Stress Complex (ER-UPR).
    Lobo GP; Ebke LA; Au A; Hagstrom SA
    Adv Exp Med Biol; 2016; 854():223-30. PubMed ID: 26427415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FBXO32 activates NF-κB through IκBα degradation in inflammatory and genotoxic stress.
    Meshram SN; Paul D; Manne R; Choppara S; Sankaran G; Agrawal Y; Santra MK
    Int J Biochem Cell Biol; 2017 Nov; 92():134-140. PubMed ID: 28970077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAFbx/Atrogin-1 is required for atrophic remodeling of the unloaded heart.
    Baskin KK; Rodriguez MR; Kansara S; Chen W; Carranza S; Frazier OH; Glass DJ; Taegtmeyer H
    J Mol Cell Cardiol; 2014 Jul; 72():168-76. PubMed ID: 24650875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad3 Couples Pak1 With the Antihypertrophic Pathway Through the E3 Ubiquitin Ligase, Fbxo32.
    Tsui H; Zi M; Wang S; Chowdhury SK; Prehar S; Liang Q; Cartwright EJ; Lei M; Liu W; Wang X
    Hypertension; 2015 Dec; 66(6):1176-83. PubMed ID: 26483344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells.
    Habel N; El-Hachem N; Soysouvanh F; Hadhiri-Bzioueche H; Giuliano S; Nguyen S; Horák P; Gay AS; Debayle D; Nottet N; Béranger G; Paillerets BB; Bertolotto C; Ballotti R
    Cell Death Differ; 2021 Jun; 28(6):1837-1848. PubMed ID: 33462405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SerpinB5 interacts with KHDRBS3 and FBXO32 in gastric cancer cells.
    Lei KF; Liu BY; Wang YF; Chen XH; Yu BQ; Guo Y; Zhu ZG
    Oncol Rep; 2011 Nov; 26(5):1115-20. PubMed ID: 21725612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel BAG5 variant impairs the ER stress response pathway, causing dilated cardiomyopathy and arrhythmia.
    Wongong R; Kijtawornrat A; Srichomthong C; Tongkobpeth S; Od-Ek P; Assawapitaksakul A; Caengprasath N; Khongphatthanayothin A; Porntaveetus T; Shotelersuk V
    Sci Rep; 2024 May; 14(1):11980. PubMed ID: 38796549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FBXO32 promotes microenvironment underlying epithelial-mesenchymal transition via CtBP1 during tumour metastasis and brain development.
    Sahu SK; Tiwari N; Pataskar A; Zhuang Y; Borisova M; Diken M; Strand S; Beli P; Tiwari VK
    Nat Commun; 2017 Nov; 8(1):1523. PubMed ID: 29142217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.